HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma

被引：0
作者：
Gabarre, J
Bossi, P
机构：
[1] Hop La Pitie Salpetriere, Serv Hematol Clin, F-75013 Paris, France
[2] Hop La Pitie Salpetriere, Serv Malad Infect & Trop, F-75013 Paris, France
来源：
BULLETIN DU CANCER | 2003年 / 90卷 / 05期
关键词：
HIV; HAART;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Highly active antiretroviral therapy (HAART) has changed the epidemiology of Kaposi's sarcoma (KS) and lymphoma occurring in people living with HIV The KS's decrease was observed early after HAART availability; although delayed, the decrease of non-Hodgkin's lymphoma has been significant. The improvement of immune status due to HAART has decreased the occurrence of chemotherapy triggered opportunistic infections, and survival rates have been improved. The administration of chemotherapy with HAART does not seem to increase toxiciy.
引用
收藏
页码：419 / 425
页数：7
相关论文
共 53 条
  • [1] The epidemiologic, pathologic, and clinical features of AIDS-associated pulmonary Kaposi's sarcoma
    Aboulafia, DM
    [J]. CHEST, 2000, 117 (04) : 1128 - 1145
  • [2] Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy
    Antinori, A
    Cingolani, A
    Alba, L
    Ammassari, A
    Serraino, D
    Ciancio, BC
    Palmieri, F
    De Luca, A
    Larocca, LM
    Ruco, L
    Ippolito, G
    Cauda, R
    [J]. AIDS, 2001, 15 (12) : 1483 - 1491
  • [3] Kaposi's sarcoma
    Antman, K
    Chang, Y
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (14) : 1027 - 1038
  • [4] KAPOSIS SARCOMA AMONG PERSONS WITH AIDS - A SEXUALLY-TRANSMITTED INFECTION
    BERAL, V
    PETERMAN, TA
    BERKELMAN, RL
    JAFFE, HW
    [J]. LANCET, 1990, 335 (8682) : 123 - 128
  • [5] CANCER SURVEYS - CANCER, HIV AND AIDS
    BERAL, V
    JAFFE, H
    WEISS, R
    [J]. EUROPEAN JOURNAL OF CANCER, 1991, 27 (08) : 1057 - 1058
  • [6] Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy
    Besson, C
    Goubar, A
    Gabarre, J
    Rozenbaum, W
    Pialoux, G
    Châtelet, FP
    Katlama, C
    Charlotte, F
    Dupont, B
    Brousse, N
    Huerre, M
    Mikol, J
    Camparo, P
    Mokhtari, K
    Tulliez, M
    Salmon-Céron, D
    Boué, F
    Costagliola, D
    Raphaël, M
    [J]. BLOOD, 2001, 98 (08) : 2339 - 2344
  • [7] Bi J, 2001, J ACQ IMMUN DEF SYND, V28, P416, DOI 10.1097/00042560-200112150-00002
  • [8] Biggar RJ, 2001, J ACQ IMMUN DEF SYND, V26, P371, DOI 10.1097/00126334-200104010-00015
  • [9] Buchbinder SP, 1999, J ACQ IMMUN DEF SYND, V21, pS23
  • [10] Recent advances in the treatment of AIDS-related Kaposi's sarcoma
    Cattelan A.M.
    Trevenzoli M.
    Aversa S.M.L.
    [J]. American Journal of Clinical Dermatology, 2002, 3 (7) : 451 - 462
123456